SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹717 Cr | ₹514 Cr | ₹420 Cr | ₹344 Cr | ₹213 Cr |
What is the latest Total Liabilities ratio of SUDEEP PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹717 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹420 Cr |
| Mar2022 | ₹344 Cr |
| Mar2021 | ₹213 Cr |
How is Total Liabilities of SUDEEP PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹717 Cr | 39.56 | |
| Mar2024 | ₹514 Cr | 22.42 | |
| Mar2023 | ₹420 Cr | 22.04 | |
| Mar2022 | ₹344 Cr | 61.64 | |
| Mar2021 | ₹213 Cr | - | |
Compare Total Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,135.3 Cr | -4.2% | 16.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -4.2% |
16.3% |
|
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses